Survivorship care for patients with prostate cancer requires careful consideration of unique disease-specific factors, including the prolonged natural disease history, the potential for competing health risks, and the consequences of long-term androgen deprivation therapy. However, current prostate cancer survivorship research is unfortunately limited by the lack of a robust supportive evidence base, variability in the definitions and measurement of survivorship outcomes, and a heavy reliance on expert opinion. As a result, the conduct of quality prostate cancer survivorship research is of increasing importance for patients, medical providers, and other key stakeholders. This manuscript harmonizes a path forward for improving prostate cancer survivorship by defining prostate cancer survivorship and survivorship research, as well as by highlighting key research priorities and cooperative mechanisms for survivorship studies within prostate cancer, with a particular focus on men with advanced disease.
|Original language||English (US)|
|Number of pages||11|
|Journal||Urologic Oncology: Seminars and Original Investigations|
|State||Published - Mar 2020|
Bibliographical noteFunding Information:
The authors wish to acknowledge the Prostate Cancer Foundation for supporting the development of the Survivorship Research in Prostate Cancer Working Group (SuRECaP), as well as ongoing prostate cancer survivorship research.
- Improving research
- Prostate cancer
- Prostate cancer survivorship
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't